Nishan M Desilva - Net Worth and Insider Trading
Nishan M Desilva Net Worth
The estimated net worth of Nishan M Desilva is at least $3 Million dollars as of 2024-11-13. Nishan M Desilva is the VP, Finance & Strategy and CFO of Ligand Pharmaceuticals Inc and owns about 22,282 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $3 Million. Nishan M Desilva is also the Director of Cartesian Therapeutics Inc and owns about 233 shares of Cartesian Therapeutics Inc (RNAC) stock worth over $3,945. Details can be seen in Nishan M Desilva's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nishan M Desilva has not made any transactions after 2021-12-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Nishan M Desilva
Nishan M Desilva Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nishan M Desilva owns 2 companies in total, including Ligand Pharmaceuticals Inc (LGND) , and Cartesian Therapeutics Inc (RNAC) .
Click here to see the complete history of Nishan M Desilva’s form 4 insider trades.
Insider Ownership Summary of Nishan M Desilva
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2015-05-14 | VP & Corporate Development |
| RNAC | Cartesian Therapeutics Inc | 2021-12-02 | director |
Nishan M Desilva Latest Holdings Summary
Nishan M Desilva currently owns a total of 2 stocks. Among these stocks, Nishan M Desilva owns 22,282 shares of Ligand Pharmaceuticals Inc (LGND) as of May 14, 2015, with a value of $3 Million and a weighting of 99.85%. Nishan M Desilva also owns 233 shares of Cartesian Therapeutics Inc (RNAC) as of December 2, 2021, with a value of $3,945 and a weighting of 0.15%.
Latest Holdings of Nishan M Desilva
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2015-05-14 | 22,282 | 120.74 | 2,690,329 |
| RNAC | Cartesian Therapeutics Inc | 2021-12-02 | 233 | 16.93 | 3,945 |
Holding Weightings of Nishan M Desilva
Nishan M Desilva Form 4 Trading Tracker
According to the SEC Form 4 filings, Nishan M Desilva has made a total of 0 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 68,363 shares on May 14, 2015, which brought Nishan M Desilva around $6 Million.
According to the SEC Form 4 filings, Nishan M Desilva has made a total of 1 transactions in Cartesian Therapeutics Inc (RNAC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cartesian Therapeutics Inc is the acquisition of 233 shares on December 2, 2021, which cost Nishan M Desilva around $20,720.
Insider Trading History of Nishan M Desilva
- 1
Nishan M Desilva Trading Performance
GuruFocus tracks the stock performance after each of Nishan M Desilva's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nishan M Desilva is -13.35%. GuruFocus also compares Nishan M Desilva's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nishan M Desilva within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nishan M Desilva's insider trading performs compared to the benchmark.
Performance of Nishan M Desilva
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 18.97 | | | | | |
| Relative Return to S&P 500(%) | 14.25 | | | | | |
Nishan M Desilva Ownership Network
Ownership Network List of Nishan M Desilva
Ownership Network Relation of Nishan M Desilva
Nishan M Desilva Owned Company Details
What does Ligand Pharmaceuticals Inc do?
Who are the key executives at Ligand Pharmaceuticals Inc?
Nishan M Desilva is the VP & Corporate Development of Ligand Pharmaceuticals Inc. Other key executives at Ligand Pharmaceuticals Inc include CHIEF LEGAL OFFICER & Andrew Reardon , VP & Finance and CFO Matthew E Korenberg , and Chief Financial Officer Octavio Espinoza .
Ligand Pharmaceuticals Inc (LGND) Insider Trades Summary
Over the past 18 months, Nishan M Desilva made no insider transaction in Ligand Pharmaceuticals Inc (LGND). Other recent insider transactions involving Ligand Pharmaceuticals Inc (LGND) include a net sale of 70,748 shares made by Matthew E Korenberg , a net sale of 14,708 shares made by Octavio Espinoza , and a net sale of 13,500 shares made by Andrew Reardon .
In summary, during the past 3 months, insiders sold 39,680 shares of Ligand Pharmaceuticals Inc (LGND) in total and bought 0 shares, with a net sale of 39,680 shares. During the past 18 months, 106,227 shares of Ligand Pharmaceuticals Inc (LGND) were sold and 6,500 shares were bought by its insiders, resulting in a net sale of 99,727 shares.
Ligand Pharmaceuticals Inc (LGND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ligand Pharmaceuticals Inc Insider Transactions
Nishan M Desilva Mailing Address
Above is the net worth, insider trading, and ownership report for Nishan M Desilva. You might contact Nishan M Desilva via mailing address: 11119 North Torrey Pines Rd Ste 200, La Jolla Ca 92037.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
